← Back to catalogue

Evolysse Form

FDA UDI

Class III (US FDA UDI)

by Symatese

Identity

Trade Name
EVOLYSSE FORM FDA UDI
Generic Name
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI
Device Name
Dermal HA filler for NLF - Demo FDA UDI
Model / Reference
EVOF1F001-D FDA UDI
Description
Dermal HA filler for NLF - Demo FDA UDI

Identifiers

Catalog Number
EVO-FRM-01-D FDA UDI
Primary DI / UDI-DI
03760172161295 FDA UDI
PMA Number
P240022 FDA UDI
FDA Product Code
LMH FDA UDI
GMDN Term
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

Yes

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Dermal tissue reconstructive material, microbe-derived, anaesthetic

Evolysse Form by Symatese — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Dermal tissue reconstructive material, microbe-derived, anaesthetic.

Cleared under the same submission

P240022 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Symatese

Sources (1)

  • FDA UDI ff9c50cc-561f-4c9f-88d2-7513413dc940 35 fields · synced Jun 8, 2026